Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
34,142
Value
$335.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of OCUL by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202634,142$335.3K<0.1%−2,850−7.7%ReducedHolders
Q1 202636,992$313.3K<0.1%−6,332−14.6%ReducedHolders
Q4 202543,324$526.0K<0.1%+13,089+43.3%AddedHolders
Q3 202530,235$353.4K<0.1%−4,540−13.1%ReducedHolders
Q2 202534,775$322.7K<0.1%−6,543−15.8%ReducedHolders
Q1 202541,318$302.9K<0.1%−9,952−19.4%ReducedHolders
Q4 202451,270$437.8K<0.1%+12,669+32.8%AddedHolders
Q3 202438,601$335.8K<0.1%+13,552+54.1%AddedHolders
Q2 202425,049$171.3K<0.1%−3,449−12.1%ReducedHolders
Q1 202428,498$259.3K<0.1%+10,194+55.7%AddedHolders
Q4 202318,304$81.6K<0.1%+2,985+19.5%AddedHolders
Q3 202315,319$48.1K<0.1%+153+1.0%AddedHolders
Q2 202315,166$78.3K<0.1%+758+5.3%AddedHolders
Q1 202314,408$75.9K<0.1%−1,876−11.5%ReducedHolders
Q4 202216,284$45.8K<0.1%+1,298+8.7%AddedHolders
Q3 202214,986$62.0K<0.1%+353+2.4%AddedHolders
Q2 202214,633$59.0K<0.1%−7,683−34.4%ReducedHolders
Q1 202222,316$111.0K<0.1%−5,216−18.9%ReducedHolders
Q4 202127,532$192.0K<0.1%+1,347+5.1%AddedHolders
Q3 202126,185$262.0K<0.1%−7,409−22.1%ReducedHolders
Q2 202133,594$476.0K<0.1%+3,709+12.4%AddedHolders
Q1 202129,885$490.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.